NeuroMetrix, Inc. CEO To Present At 29th Annual Meeting Of Japan Society Of Diabetic Complications

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of The Japan Society of Diabetic Complications to be held in Tokyo on October 3 and 4, 2014. The Japan Society of Diabetic Complications is a part of The Japan Diabetes Society which was established in 1958 to promote diabetes-related academic research and treatment programs.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC